Cargando…
Satralizumab for neuromyelitis optica spectrum disorder
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882450/ https://www.ncbi.nlm.nih.gov/pubmed/35233140 http://dx.doi.org/10.18773/austprescr.2021.065 |
_version_ | 1784659703162208256 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8882450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-88824502022-02-28 Satralizumab for neuromyelitis optica spectrum disorder Aust Prescr New Drugs NPS MedicineWise 2021-12-10 2022-02 /pmc/articles/PMC8882450/ /pubmed/35233140 http://dx.doi.org/10.18773/austprescr.2021.065 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | New Drugs Satralizumab for neuromyelitis optica spectrum disorder |
title | Satralizumab for neuromyelitis optica spectrum disorder |
title_full | Satralizumab for neuromyelitis optica spectrum disorder |
title_fullStr | Satralizumab for neuromyelitis optica spectrum disorder |
title_full_unstemmed | Satralizumab for neuromyelitis optica spectrum disorder |
title_short | Satralizumab for neuromyelitis optica spectrum disorder |
title_sort | satralizumab for neuromyelitis optica spectrum disorder |
topic | New Drugs |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882450/ https://www.ncbi.nlm.nih.gov/pubmed/35233140 http://dx.doi.org/10.18773/austprescr.2021.065 |